Overview

Intravenous Versus Intraperitoneal Instillation of Ondansetron for Decreasing Incidence of Nausea and Vomiting After Laparoscopic Gynecological Surgeries.

Status:
Not yet recruiting

Trial end date:
2022-10-15

Target enrollment:

Participant gender:

Summary

Study the effect of intraperitoneal instillation vs intravenous ondansetron on PONV added to intraperitoneal bupivacaine for enhanced recovery and to decrease incidence of PONV after laparoscopic surgeries.

Phase:

Early Phase 1

Details

Lead Sponsor:

Zagazig University

Treatments:

Bupivacaine
Ondansetron